Editorial: Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options

被引：1
作者：
Zaorsky, Nicholas G. [1 ]
Spratt, Daniel E. [2 ]
Kishan, Amar U. [3 ]
Culp, Stephen H. [4 ]
Showalter, Timothy N. [5 ]
机构：
[1] Penn State Canc Inst, Dept Radiat Oncol, Hershey, PA USA
[2] Univ Michigan, Dept Radiat Oncol, Michigan Med, Ann Arbor, MI 48109 USA
[3] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA
[4] Univ Virginia, Dept Urol, Charlottesville, VA USA
[5] Univ Virginia, Sch Med, Dept Radiat Oncol, Charlottesville, VA 22908 USA
来源：
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
基金：
美国国家卫生研究院;
关键词：
high risk prostate cancer; androgen deprivation therapy; radical prostatecomy; recurrent prostate cancer; radiation therapy; RADICAL PROSTATECTOMY; BRACHYTHERAPY BOOST; RADIOTHERAPY;
D O I：
10.3389/fonc.2020.01616
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 9 条
  • [1] Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study
    Culp, Stephen H.
    Schellhammer, Paul F.
    Williams, Michael B.
    [J]. EUROPEAN UROLOGY, 2014, 65 (06) : 1058 - 1066
  • [2] Greenberger Benjamin A, 2020, Eur Urol Focus, V6, P404, DOI 10.1016/j.euf.2019.11.007
  • [3] Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer
    Kishan, Amar U.
    Cook, Ryan R.
    Ciezki, Jay P.
    Ross, Ashley E.
    Pomerantz, Mark M.
    Nguyen, Paul L.
    Shaikh, Talha
    Tian, Phuoc T.
    Sandler, Kiri A.
    Stock, Richard G.
    Merrick, Gregory S.
    Demanes, D. Jeffrey
    Spratt, Daniel E.
    Abu-Isa, Eyad I.
    Wedde, Trude B.
    Lilleby, Wolfgang
    Krauss, Daniel J.
    Shaw, Grace K.
    Alam, Ridwan
    Reddy, Chandana A.
    Stephenson, Andrew J.
    Klein, Eric A.
    Song, Daniel Y.
    Tosoian, Jeffrey J.
    Hegde, John V.
    Yoo, Sun Mi
    Fiano, Ryan
    D'Amico, Anthony V.
    Nickols, Nicholas G.
    Aronson, William J.
    Sadeghi, Ahmad
    Greco, Stephen
    Deville, Curtiland
    McNutt, Todd
    DeWeese, Theodore L.
    Reiter, Robert E.
    Said, Johnathan W.
    Steinberg, Michael L.
    Hoiwitz, Eric M.
    Kupelian, Patrick A.
    King, Christopher R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (09): : 896 - 905
  • [4] Oligometastatic prostate cancer: The game is afoot
    Lancia, Andrea
    Zilli, Thomas
    Achard, Verane
    Dirix, Piet
    Everaerts, Wouter
    Gomez-Iturriaga, Alfonso
    Ingrosso, Gianluca
    Liefhooghe, Nick
    Miralbell, Raymond
    Siva, Shankar
    Van der Eecken, Kim
    Ost, Piet
    [J]. CANCER TREATMENT REVIEWS, 2019, 73 : 84 - 90
  • [5] Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
    Morris, W. James
    Tyldesley, Scott
    Rodda, Sree
    Halperin, Ross
    Pai, Howard
    McKenzie, Michael
    Duncan, Graeme
    Morton, Gerard
    Hamm, Jeremy
    Murray, Nevin
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : 275 - 285
  • [6] Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
    Parker, Christopher C.
    James, Nicholas D.
    Brawley, Christopher D.
    Clarke, Noel W.
    Hoyle, Alex P.
    Ali, Adnan
    Ritchie, Alastair W. S.
    Attard, Gerhardt
    Chowdhury, Simon
    Cross, William
    Dearnaley, David P.
    Gillessen, Silke
    Gilson, Clare
    Jones, Robert J.
    Langley, Ruth E.
    Malik, Zafar I.
    Mason, Malcolm D.
    Matheson, David
    Millman, Robin
    Russell, J. Martin
    Thalmann, George N.
    Amos, Claire L.
    Alonzi, Roberto
    Bahl, Amit
    Birtle, Alison
    Din, Omar
    Douis, Hassan
    Eswar, Chinnamani
    Gale, Joanna
    Gannon, Melissa R.
    Jonnada, Sai
    Khaksar, Sara
    Lester, Jason F.
    O'Sullivan, Joe M.
    Parikh, Omi A.
    Pedley, Ian D.
    Pudney, Delia M.
    Sheehan, Denise J.
    Srihari, Narayanan Nair
    Tran, Anna T. H.
    Parmar, Mahesh K. B.
    Sydes, Matthew R.
    [J]. LANCET, 2018, 392 (10162) : 2353 - 2366
  • [7] Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer The ORIOLE Phase 2 Randomized Clinical Trial
    Phillips, Ryan
    Shi, William Yue
    Deek, Matthew
    Radwan, Noura
    Lim, Su Jin
    Antonarakis, Emmanuel S.
    Rowe, Steven P.
    Ross, Ashley E.
    Gorin, Michael A.
    Deville, Curtiland
    Greco, Stephen C.
    Wang, Hailun
    Denmeade, Samuel R.
    Paller, Channing J.
    Dipasquale, Shirl
    DeWeese, Theodore L.
    Song, Daniel Y.
    Wang, Hao
    Carducci, Michael A.
    Pienta, Kenneth J.
    Pomper, Martin G.
    Dicker, Adam P.
    Eisenberger, Mario A.
    Alizadeh, Ash A.
    Diehn, Maximilian
    Tran, Phuoc T.
    [J]. JAMA ONCOLOGY, 2020, 6 (05) : 650 - 659
  • [8] SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer
    Stranne, J.
    Brasso, K.
    Brennhovd, B.
    Johansson, E.
    Jaderling, F.
    Kouri, M.
    Lilleby, W.
    Petersen, P. Meidahl
    Mirtti, T.
    Pettersson, A.
    Rannikko, A.
    Thellenberg, C.
    Akre, O.
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY, 2018, 52 (5-6) : 313 - 320
  • [9] Multimodality Therapy for Patients With High-Risk Prostate Cancer: Current Status and Future Directions
    Zaorsky, Nicholas G.
    Trabulsi, Edouard J.
    Lin, Jianqing
    Den, Robert B.
    [J]. SEMINARS IN ONCOLOGY, 2013, 40 (03) : 308 - 321
1